SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-007061
Filing Date
2023-01-26
Accepted
2023-01-26 17:11:46
Documents
17
Period of Report
2023-01-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm234557d1_8k.htm   iXBRL 8-K 44184
2 EXHIBIT 3.1 tm234557d1_ex3-1.htm EX-3.1 121367
3 EXHIBIT 3.2 tm234557d1_ex3-2.htm EX-3.2 40403
4 EXHIBIT 99.1 tm234557d1_ex99-1.htm EX-99.1 11676
8 GRAPHIC tm234557d1_ex99-1img001.jpg GRAPHIC 7652
9 GRAPHIC tm234557d1_ex99-1img002.jpg GRAPHIC 13622
  Complete submission text file 0001104659-23-007061.txt   471726

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA agrx-20230125.xsd EX-101.SCH 3060
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE agrx-20230125_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agrx-20230125_pre.xml EX-101.PRE 22613
11 EXTRACTED XBRL INSTANCE DOCUMENT tm234557d1_8k_htm.xml XML 3724
Mailing Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635
Business Address 500 COLLEGE ROAD EAST SUITE 310 PRINCETON NJ 08540-6635 609-683-1880
AGILE THERAPEUTICS INC (Filer) CIK: 0001261249 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36464 | Film No.: 23558600
SIC: 2834 Pharmaceutical Preparations